Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Helix BioMedix Inc. (HXBM) had Free Cash Flow per Share of $-13.97 for the most recently reported fiscal year, ending 2011-12-31.
| Income Statement Financials | |
$1.89M |
|
$-2.48M |
|
$0.73M |
|
$1.16M |
|
$4.28M |
|
$-2.39M |
|
$-0.08M |
|
$-2.48M |
|
$-2.48M |
|
$-2.48M |
|
$-2.49M |
|
$-2.49M |
|
$-2.48M |
|
$-2.39M |
|
$-2.29M |
|
0.16M |
|
0.16M |
|
$-15.15 |
|
$-15.15 |
|
| Balance Sheet Financials | |
$2.55M |
|
$0.02M |
|
$0.40M |
|
$2.97M |
|
$0.41M |
|
-- |
|
$0.02M |
|
$0.44M |
|
$2.54M |
|
$2.39M |
|
$2.53M |
|
-- |
|
| Cash Flow Statement Financials | |
$-2.29M |
|
$-0.05M |
|
$0.00M |
|
$4.04M |
|
$1.68M |
|
$-2.35M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.22 |
|
-- |
|
-- |
|
-- |
|
-- |
|
60.85% |
|
-126.45% |
|
-126.45% |
|
-121.16% |
|
-131.22% |
|
-131.22% |
|
$-2.29M |
|
-- |
|
-- |
|
-- |
|
0.64 |
|
2.03 |
|
7.88 |
|
46.35 |
|
-97.99% |
|
-104.14% |
|
-83.80% |
|
-98.38% |
|
-- |
|
|
Free Cash Flow per Share |
$-13.97 |
$-13.95 |
|